MD Biosciences Signs the Marseille Declaration
MD Biosciences has signed the Marseille Declaration, the first joint pharmaceutical industry statement on animal housing and use. By signing, we...
International Congress on Neuropathic Pain 2025
We had the opportunity to present at NeuPSIG 2025 in Berlin, sharing our latest findings in neuropathic pain research. The conference offered...
How Close Are We to Clinical Translation? Large-Animal Models for SCI
Spinal cord injury (SCI) remains one of the most challenging neurological conditions to treat, with few therapies successfully translating from the...
Approaches to Designing Preclinical Studies That Reflect Clinical Reality
Bridging the gap between preclinical and clinical research remains one of the most pressing challenges in drug development. While early-stage studies...
EWMA 2025: Groundbreaking AI-Driven Advancements in Wound Healing Models
MD Biosciences presented at the European Wound Management Association 2025 in Barcelona. Dr. Avital Schauder showcased groundbreaking research on...
New Poster: Peripheral Nerve injury Models
MD Biosciences attended the Peripheral Nerve Society 2025 and presented on our pig peripheral nerve injury model. The poster presents the development...
The Rehoming of Göttingen Minipigs
At MD Biosciences, we are committed to ethical responsibility in animal welfare, ensuring the highest standards of care in preclinical research. As...
Behavioral Assessments in Preclinical Models
Neurological diseases often result in a combination of motor and cognitive deficits. To gain a broader understanding of the underlying biological...
Animal Welfare in Preclinical Studies
Maintaining high standards of animal welfare in preclinical research is crucial for both ethical integrity and scientific reliability. Proper pig...